Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
176.73
-0.19 (-0.11%)
Nov 28, 2025, 4:00 PM EST - Market closed
Jazz Pharmaceuticals (JAZZ) Revenue by Segment
History
| Date | Neuroscience | Oncology |
|---|---|---|
| Jun 30, 2025 | 2.75B | 1.08B |
| Mar 31, 2025 | 2.72B | 1.08B |
| Dec 31, 2024 | 2.70B | 1.11B |
| Sep 30, 2024 | 2.66B | 1.09B |
| Jun 30, 2024 | 2.63B | 1.07B |
| Mar 31, 2024 | 2.64B | 1.04B |
| Dec 31, 2023 | 2.71B | 1.02B |
| Sep 30, 2023 | 2.76B | 965.36M |
| Jun 30, 2023 | 2.80B | 928.30M |
| Mar 31, 2023 | 2.80B | 905.92M |
| Dec 31, 2022 | 2.76B | 873.84M |
| Sep 30, 2022 | 2.71B | 857.05M |
| Jun 30, 2022 | 2.64B | 818.48M |
| Mar 31, 2022 | 2.52B | 752.44M |
| Dec 31, 2021 | 2.34B | 733.81M |
| Sep 30, 2021 | 2.11B | 723.21M |
| Jun 30, 2021 | 1.92B | 676.58M |
| Mar 31, 2021 | 1.80B | 650.94M |
| Dec 31, 2020 | 1.79B | 590.65M |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.